Author details

Full Name

David F Ransohoff

Affiliation

ORCID

Career Start Year

1976

Papers

177

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36745894	In adults, sigmoidoscopy screening invitation reduced CRC incidence and related mortality at 15 y.		2023
37463757	An efficient strategy for evaluating new non-invasive screening tests for colorectal cancer: the guiding principles.	Gut	2023
36745897	In adults, a single colonoscopy screening invitation vs. no invitation reduced CRC incidence at 10 y.		2023
34545024	New scoring systems for predicting advanced proximal neoplasia in asymptomatic adults with or without knowing distal colorectal findings: a prospective, cross-sectional study.	European Journal of Cancer Prevention	2022
35134969	Counting Advanced Precancerous Lesions as True Positives When Determining Colorectal Cancer Screening Test Specificity.	J Natl Cancer Inst	2022
32761203	Evaluating a New Cancer Screening Blood Test: Unintended Consequences and the Need for Clarity in Policy Making.	Journal of the National Cancer Institute	2021
32994311	Derivation and validation of a predictive model for advanced colorectal neoplasia in asymptomatic adults.	Gut	2021
31563625	Colorectal Cancer Incidence and Mortality After Removal of Adenomas During Screening Colonoscopies.	Gastroenterology	2020
30721924	Meeting report from the joint IARC-NCI international cancer seminar series: a focus on colorectal cancer.	Ann Oncol	2019
30165051	Mortality From Postscreening (Interval) Colorectal Cancers Is Comparable to That From Cancer in Unscreened Patients-A Randomized Sigmoidoscopy Trial.	Gastroenterology	2018
27582444	Risk of Advanced Neoplasia Using the National Cancer Institute's Colorectal Cancer Risk Assessment Tool.	Journal of the National Cancer Institute	2017
28425279	Screening for Colorectal Neoplasia.	New England Journal of Medicine	2017
27882502	Institutional Responsibility and the Flawed Genomic Biomarkers at Duke University: A Missed Opportunity for Transparency and Accountability.	Sci Eng Ethics	2017
27042931	Rationale and design of the European Polyp Surveillance (EPoS) trials.	Endoscopy	2016
27304798	Clinical Practice Guidelines for Colorectal Cancer Screening: New Recommendations and New Challenges.	JAMA - Journal of the American Medical Association	2016
26926450	Reply.	Gastroenterology	2016
26420882	Predictive Value Tools as an Aid in Chemopreventive Agent Development.	Journal of the National Cancer Institute	2015
25688116	Leveraging biospecimen resources for discovery or validation of markers for early cancer detection.	J Natl Cancer Inst	2015
25560730	Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration.	Ann Intern Med	2015
26259154	Derivation and Validation of a Scoring System to Stratify Risk for Advanced Colorectal Neoplasia in Asymptomatic Adults: A Cross-sectional Study.	Annals of Internal Medicine	2015
24645800	Multitarget stool DNA testing for colorectal-cancer screening.	New England Journal of Medicine	2014
24333512	Endoscopic detection of proximal serrated lesions and pathologic identification of sessile serrated adenomas/polyps vary on the basis of center.	Clinical Gastroenterology and Hepatology	2014
23408352	Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer.	Gut	2014
24807866	Addressing overdiagnosis and overtreatment in cancer: a prescription for change.	Lancet Oncol	2014
25006736	Multitarget stool DNA testing for colorectal-cancer screening.	New England Journal of Medicine	2014
24560454	What is the effect of more sensitive diagnostic technology?	Lancet Oncology, The	2014
23652517	Development of trustworthy practice guidelines--reply.	JAMA - Journal of the American Medical Association	2013
23903752	Breaking a vicious cycle.	Sci Transl Med	2013
24063748	Statistical design for biospecimen cohort size in proteomics-based biomarker discovery and verification studies.	J Proteome Res	2013
23752106	Guidelines for guidelines: measuring trustworthiness.	Journal of Clinical Oncology	2013
23299601	How to decide whether a clinical practice guideline is trustworthy.	JAMA - Journal of the American Medical Association	2013
23462919	Cultivating cohort studies for observational translational research.	Cancer Epidemiology Biomarkers and Prevention	2013
23462917	Transforming epidemiology for 21st century medicine and public health.	Cancer Epidemiol Biomarkers Prev	2013
23212726	European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication.	Endoscopy	2013
23660420	Colon cancer screening models: lessons and challenges.	Clinical Gastroenterology and Hepatology	2013
23412608	How can polygenic inheritance be used in population screening for common diseases?	Genet Med	2013
22256806	Bone-density testing interval and transition to osteoporosis in older women.	N Engl J Med	2012
22586009	Risk for colorectal cancer in persons with a family history of adenomatous polyps: a systematic review.	Annals of Internal Medicine	2012
22539065	Screening colonoscopy in the US: attitudes and practices of primary care physicians.	Journal of General Internal Medicine	2012
24451831	Why Hasn't Genomic Testing Changed the Landscape in Clinical Oncology?	Am Soc Clin Oncol Educ Book	2012
23062404	Tailoring colorectal cancer screening by considering risk of advanced proximal neoplasia.	American Journal of Medicine	2012
21698368	Recommendations for post-polypectomy surveillance in community practice.	Digestive Diseases and Sciences	2011
21434890	Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration.	Eur J Clin Invest	2011
21424820	Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration.	Eur J Epidemiol	2011
21372037	A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer.	Cancer Prev Res (Phila)	2011
21414753	Strengthening the reporting of Genetic RIsk Prediction Studies (GRIPS): explanation and elaboration.	J Clin Epidemiol	2011
21364690	Biomarker studies: a call for a comprehensive biomarker study registry.	Nat Rev Clin Oncol	2011
21407270	Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration.	Eur J Hum Genet	2011
21757648	Using models to make policy: an inflection point?	Medical Decision Making	2011
21757647	Cross-model comparisons to improve the value of modeling: the case of colorectal cancer screening.	Medical Decision Making	2011